TORONTO, Dec. 23, 2025 /CNW/ - BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), approving TEVIMBRA® (tislelizumab for injection) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback